[HTML][HTML] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmüllner… - Respiratory …, 2010 - Springer
Background The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms …
R Eccles, C Meier, M Jawad, R Weinmüllner… - Respiratory …, 2010 - infona.pl
Background The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms …
R Eccles, C Meier, M Jawad, R Weinmüllner… - Respiratory …, 2010 - hero.epa.gov
BACKGROUND: The common cold, the most prevalent contagious viral disease in humans
still lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
still lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
[PDF][PDF] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmüllner… - 2010 - academia.edu
Background: The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
[PDF][PDF] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmüllner… - 2010 - nasitrol.com
Background: The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
[PDF][PDF] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmüllner… - 2010 - marinomed.com
Background: The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
[HTML][HTML] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad… - Respiratory …, 2010 - respiratory-research.biomedcentral …
The common cold, the most prevalent contagious viral disease in humans still lacks a safe
and effective antiviral treatment. Iota-Carrageenan is broadly active against respiratory …
and effective antiviral treatment. Iota-Carrageenan is broadly active against respiratory …
[HTML][HTML] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmüllner… - Respiratory …, 2010 - ncbi.nlm.nih.gov
Background The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms …
R Eccles, C Meier, M Jawad, R Weinmüllner… - Respiratory …, 2010 - europepmc.org
Background The common cold, the most prevalent contagious viral disease in humans still
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
lacks a safe and effective antiviral treatment. Iota-Carrageenan is broadly active against …
[引用][C] Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early …
R Eccles, C Meier, M Jawad, R Weinmullner… - Respiratory …, 2010 - go.gale.com
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind,
placebo-controlled exploratory study in volunteers with early symptoms of the common cold …
placebo-controlled exploratory study in volunteers with early symptoms of the common cold …